Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.02 USD | -1.96% | +8.88% | +23.49% |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Mar. 28 | Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 4.81M | Sales 2023 | 2.13M | Capitalization | 13.57M |
---|---|---|---|---|---|
Net income 2022 | -113M | Net income 2023 | -62M | EV / Sales 2022 | -17.6 x |
Net cash position 2022 | 96.61M | Net cash position 2023 | 57.06M | EV / Sales 2023 | -20.4 x |
P/E ratio 2022 |
-0.11
x | P/E ratio 2023 |
-0.22
x | Employees | 99 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.69% |
Latest transcript on Talis Biomedical Corporation
1 day | +2.11% | ||
1 week | +8.88% | ||
Current month | +5.15% | ||
1 month | +1.10% | ||
3 months | +17.20% | ||
6 months | +94.92% | ||
Current year | +23.49% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director of Finance/CFO | 51 | 21-12-31 | |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 16-02-29 |
Randal Scott
BRD | Director/Board Member | 66 | 13-12-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 9.2 | +2.11% | 3 352 |
24-04-23 | 9.01 | +0.11% | 8,738 |
24-04-22 | 9 | +1.12% | 9,727 |
24-04-19 | 8.9 | -1.11% | 12,351 |
24-04-18 | 9 | +6.51% | 7,693 |
Delayed Quote Nasdaq, April 24, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+23.49% | 16.76M | |
+4.09% | 43.84B | |
+47.07% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- TLIS Stock